KM Kaukonen

R Corcuera Romero de la Devesa

R Phillips

J Ruiz Moreno

E González Marín

MJ Esteve Paños

M Moral Guiteras

M Juliá Amill

N Suárez Álvarez

N Conesa Folch

F Baigorri González

A Artigas Raventós

Crossref

POSTER PRESENTATION Open AccessImpact of oncologic pathology (OP) in the evolutionof severe sepsis (SS) in the critically ill patients (CIP)J Ruiz Moreno1*, E González Marín1, MJ Esteve Paños1, R Corcuera Romero de la Devesa1, M Moral Guiteras1,M Juliá Amill1, N Suárez Álvarez1, N Conesa Folch1, F Baigorri González1, A Artigas Raventós2From ESICM LIVES 2015Berlin, Germany. 3-7 October 2015IntrIt is considered that the severity of septic CIPs is higherthan the overall CIPs requiring ICU admission. Never-theless, the impact of the OP over the severity of the SSperhaps has not been sufficiently analyzed and evaluated.ObjectivesTo evaluate the impact of the OP in the evolution of the SSof the CIPs.Methods· Study: prospective, analytical, longitudinal, andobservational· Period: January 1-2011 / June 30-2014 (42 months)· SETTING. Medical/Surgical ICU· Population: 2559 CIPs admitted consecutively to theICU; sample: 484 CIPs with SS.· Exclusión criteria: CIPs < 16 y., major burn CIPs,incomplete clinical documentation, and voluntarydischarge.· Variables analyzed:a) Ageb) Hospital mortalityc) Case - mix: metabolic acidosis, total parenteralnutrition, intra-abdominal pressure (IAP), blood pro-ducts, cultures, cardiac output, renal replacement ther-apy (RRT), advanced life support (ALS), FGC, FBC,e) Organ dysfunction: SOFA and LODSf) Limitation of life support (LLS).· Statistical analysis: Ji squared and contrast of means(Student’s t)· Limitations of the study: absence of critically burnedpatients and pediatric CIPs1QuirónSalud Hospital Universitario Sagrat Cor, Critical Care Department,Barcelona, SpainFull list of author information is available at the end of the articleTable 1Global % SS % SS with OP % SS witout OP % p valueN 2559 100 484 18,9 130 26,9 354 73,1Age 65,88 16,7 73,5 13,1 73,18 11,4 73,64 13,7 NSMortality 182 7,1 120 24,8 39 30,0 81 22,9 NSRRT 91 3,6 70 14,6 20 15,8 50 14,1 NSTPN 467 18,2 184 38,0 90 69,3 94 26,5 0,0001IAP 136 5,3 101 20,8 37 28,6 64 18,1 0,012Metb acid 955 37,3 368 76,0 113 86,9113 255 72,0 0,0006Ruiz Moreno et al. Intensive Care Medicine Experimental 2015, 3(Suppl 1):A247http://www.icm-experimental.com/content/3/S1/A247© 2015 Ruiz Moreno et al.; This is an Open Access article distributed under the terms of the Creative Commons Attribution License(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, providedthe original work is properly cited.ResultsGlobal CIPs: 2559; sepsis CIPs: 484; non sepsis CIPs:2075SOFA: Global (2.70), septic CIPs (5,32), non-septicCIPs (1,90)LODS: Global (1.37), septic CIPs (2,78), non-septicCIPs (0,94)See Tables 1 and 2.Conclusions1) The OP conditions not age or mortality of CIPswith SS.2) Metabolic acidosis and the need of TPN, IAP andblood products are higher in the SS with OP.3) Cultures, RRT, ALS, FGC, and FBC are appliedequally in both groups.4) The LLS is applied more in the SS with OP.Authors’ details1QuirónSalud Hospital Universitario Sagrat Cor, Critical Care Department,Barcelona, Spain. 2Hospital de Clínicas de Sabadell & QuirónSalud HospitalUniversitario Sagrat Cor, Critical Care Department, Sabadell, Spain.Published: 1 October 2015References1. Phillips R, Hancock B, Graham J, Bromham N, Jin H, Berendse S: Preventionand management of neutropenic sepsis in patients with cancer:summary of NICE guidance. BMJ 2012, 345:e5368.2. Corcuera Romero de la Devesa R, Ruiz Moreno J, González Marín E, EstevePaños MJ, Godayol Arias S, Conesa Folch N, Rinaudo Videla M, ArtigasRaventós A: Evaluation of severity in critically ill patientes (CIPS) withsepsis. European Society of Intensive Care Medicine, 27th Annual CongresBarcelona, Spain; 2014, September.3. Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R: Mortality Related toSevere Sepsis and Septic Shock Among Critically Ill Patients in Australiaand New Zealand, 2000-2012. JAMA 2014, 311(13):1308-1316.doi:10.1186/2197-425X-3-S1-A247Cite this article as: Ruiz Moreno et al.: Impact of oncologic pathology (OP)in the evolution of severe sepsis (SS) in the critically ill patients (CIP).Intensive Care Medicine Experimental 2015 3(Suppl 1):A247.Submit your manuscript to a journal and benefi t from:7 Convenient online submission7 Rigorous peer review7 Immediate publication on acceptance7 Open access: articles freely available online7 High visibility within the fi eld7 Retaining the copyright to your article    Submit your next manuscript at 7 springeropen.comTable 2Global % SS % SS with OP % SS witout OP % p valueBlood products 500 19,5 216 44,6 83 63,8 133 37,6 0,0001 NS NSCultures 689 26,9 456 94,2 119 91,5 337 95,2 NSPericardiocent. 8 0,3 3 0,6 2 1,5 1 0,9 NSALS 85 3,3 42 8,7 16 12,3 26 7,3 0,085FGC 54 2,1 28 5,8 8 6,1 20 5,6 NSFBC 61 2,3 47 9,7 12 9,2 35 9,9 NSLLS 220 8,6 122 25,2 41 31,5 81 22,9 0,0518Ruiz Moreno et al. Intensive Care Medicine Experimental 2015, 3(Suppl 1):A247http://www.icm-experimental.com/content/3/S1/A247Page 2 of 2

Intensive Care Medicine Experimental

Impact of oncologic pathology (OP) in the evolution of severe sepsis (SS) in the critically ill patients (CIP)

https://icm-experimental.springeropen.com/track/pdf/10.1186/2197-425X-3-S1-A247?site=icm-experimental.springeropen.com

Impact of oncologic pathology (OP) in the evolution of severe sepsis (SS) in the critically ill patients (CIP)

Abstract

Similar works

Full text

Available Versions

Crossref